RMEBX
Price
$65.68
Change
-$0.21 (-0.32%)
Updated
Aug 14 closing price
Net Assets
117.86B
SMVLX
Price
$101.40
Change
+$0.12 (+0.12%)
Updated
Aug 14 closing price
Net Assets
4.2B
Interact to see
Advertisement

RMEBX vs SMVLX

RMEBX vs SMVLX Comparison Chart in %
View a ticker or compare two or three
VS
RMEBX vs. SMVLX commentary
Aug 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMEBX is a Buy and SMVLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 118B vs. SMVLX (4.2B). SMVLX pays higher dividends than RMEBX: SMVLX (1.38) vs RMEBX (0.99). RMEBX was incepted earlier than SMVLX: RMEBX (12 years) vs SMVLX (19 years). SMVLX (1.23) is less costly to investors than RMEBX (1.07). RMEBX is a more actively managed with annual turnover of: 30.00 vs. SMVLX (16.25). RMEBX has a lower initial minimum investment than SMVLX: RMEBX (250) vs SMVLX (3000). SMVLX annual gain was more profitable for investors over the last year : 28.45 vs. RMEBX (9.66). SMVLX return over 5 years is better than : 57.66 vs. RMEBX (36.72).
RMEBXSMVLXRMEBX / SMVLX
Total Expense Ratio1.071.2387%
Annual Report Gross Expense Ratio1.071.2387%
Fund Existence12 years19 years-
Gain YTD11.52124.05248%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets118B4.2B2,812%
Annual Yield % from dividends0.991.3872%
Returns for 1 year9.6628.4534%
Returns for 3 years38.0548.2979%
Returns for 5 years36.7257.6664%
Returns for 10 years93.11179.7152%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBIO17.140.51
+3.07%
Crescent Biopharma Inc
FDSB18.350.10
+0.55%
Fifth District Bancorp Inc
SSNC81.50-0.54
-0.66%
SS&C Technologies Holdings
PLSE44.54-0.38
-0.85%
Pulse Biosciences
JZ1.87-0.63
-25.20%
Jianzhi Education Technology Group Co Ltd